TAK-733
- Generic Name
- TAK-733
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H15F2IN4O4
- CAS Number
- 1035555-63-5
- Unique Ingredient Identifier
- 5J61HSP0QJ
- Background
TAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies.
- Associated Conditions
- -
- Associated Therapies
- -
Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-07-29
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- Millennium Pharmaceuticals, Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT00948467
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸Wayne State University Karmanos Cancer Institute, Detriot, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath